UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

European journal of cancer (1990), 2012-06, Vol.48 (9), p.1283-1292

2012

Volltextzugriff (PDF)

Human DNA Repair Genes

Science (American Association for the Advancement of Science), 2001-02, Vol.291 (5507), p.1284-1289

2001

Volltextzugriff (PDF)

Recurrence rate in colorectal adenocarcinoma patients receiving adjuvant capecitabine monotherapy: do the number of chemotherapy cycles and relative dose intensity of the drug play a role?

Annals of oncology, 2019-07, Vol.30, p.iv59-iv59

2019

Volltextzugriff (PDF)

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab

The pharmacogenomics journal, 2012-12, Vol.12 (6), p.468-475

2012

Volltextzugriff (PDF)

A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D

Cancer research (Chicago, Ill.), 2000-03, Vol.60 (6), p.1690-1697

2000

Volltextzugriff (PDF)

Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study

European journal of clinical microbiology & infectious diseases, 2012-07, Vol.31 (7), p.1389-1398

2012

Volltextzugriff (PDF)

Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study

British journal of cancer, 2005-03, Vol.92 (5), p.815-819

2005

Volltextzugriff (PDF)

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

The Lancet (British edition), 2011-05, Vol.377 (9779), p.1749-1759

2011

Volltextzugriff (PDF)

The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas

Gut, 2002-06, Vol.50 (6), p.834-839

2002

Volltextzugriff (PDF)

OC-02 Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

Thrombosis research, 2010, Vol.125, p.S161-S161

2010

Volltextzugriff (PDF)

Synaptotagmins: More Isoforms Than Functions?

Biochemical and biophysical research communications, 1998-07, Vol.248 (1), p.1-8

1998

Volltextzugriff (PDF)

P-215Recurrence rate in colorectal adenocarcinoma patients receiving adjuvant capecitabine monotherapy: do the number of chemotherapy cycles and relative dose intensity of the drug play a role?

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Volltextzugriff (PDF)

PO-56 Chemoanticoagulation versus chemotherapy in advanced pancreatic cancer (APC): results of the interim analysis of the FRAGEM trial

Thrombosis research, 2007, Vol.120, p.S163-S163

2007

Volltextzugriff (PDF)

SO-2 Prevalence and prognostic role of inherited germline mutations in cancer predisposing genes in unselected patients with pancreatic cancer

Annals of oncology, 2020-07, Vol.31, p.S217

2020

Volltextzugriff (PDF)

Genotyping and mRNA profiling reveal actionable targets in biliary tract cancers

Annals of oncology, 2017-09, Vol.28, p.v246-v246

2017

Volltextzugriff (PDF)

The genome sequence of Schizosaccharomyces pombe

Nature (London), 2002-02, Vol.415 (6874), p.871-880

2002

Volltextzugriff (PDF)

Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer

Anticancer research, 2003-01, Vol.23 (1B), p.737

2003

Volltextzugriff (PDF)

Pulmonary Langerhans cell histiocytosis in a patient previously treated for germ cell tumor

Journal of B.U. ON., 2010-01, Vol.15 (1), p.194

2010

Volltextzugriff (PDF)

6503 Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

European journal of cancer supplements, 2009, Vol.7 (2), p.362-362

2009

Volltextzugriff (PDF)

Gemcitabine combined with the MTOR Inhibitor Temsirolimus(CCI-779) in Patients with Inoperable or Metastatic Pancreatic Cancer (He 3/07). A Phase I Study by the Hellenic Cooperative Oncology Group

Annals of oncology, 2012-09, Vol.23, p.ix239

2012

Volltextzugriff (PDF)

Molecular Characterization of a Human DNA Kinase

The Journal of biological chemistry, 1999-08, Vol.274 (34), p.24187-24194

1999

Volltextzugriff (PDF)

Correlation of MDR 1 Expression and CA 125 in Ovarian Cancer

In vivo (Athens), 2005-07, Vol.19 (4), p.797-800

2005

Volltextzugriff (PDF)

Cloning, mapping and expression of UBL3, a novel ubiquitin-like gene

Gene, 1999-06, Vol.233 (1), p.189-195

1999

Volltextzugriff (PDF)

A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein

The EMBO journal, 1999-07, Vol.18 (13), p.3868-3875

1999

Volltextzugriff (PDF)

The cohesin complex: sequence homologies, interaction networks and shared motifs

Genome biology, 2001-01, Vol.2 (3), p.RESEARCH0009-research0009.12, Article research0009.1

2001

Volltextzugriff (PDF)

1 – 25 von 325

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(271)

Publikationsform

Sprache

Englisch
(324)

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(128)
Humans
(118)
Biological And Medical Sciences
(69)
Medical Sciences
(64)
Male
(59)
Female
(58)
Physics
(44)
Animals
(36)
Physical Sciences
(35)
Radiology, Nuclear Medicine & Medical Imaging
(35)
Middle Aged
(32)
Adult
(29)
Physics, Nuclear
(27)
Aged
(26)
Oncology
(26)
Radioimmunotherapy
(25)
Surgery
(25)
Child
(23)
Clinical Neurology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

Human DNA Repair Genes

Recurrence rate in colorectal adenocarcinoma patients receiving adjuvant capecitabine monotherapy: do the number of chemotherapy cycles and relative dose intensity of the drug play a role?

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab

A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D

Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study

Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas

OC-02 Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

Synaptotagmins: More Isoforms Than Functions?

P-215Recurrence rate in colorectal adenocarcinoma patients receiving adjuvant capecitabine monotherapy: do the number of chemotherapy cycles and relative dose intensity of the drug play a role?

PO-56 Chemoanticoagulation versus chemotherapy in advanced pancreatic cancer (APC): results of the interim analysis of the FRAGEM trial

SO-2 Prevalence and prognostic role of inherited germline mutations in cancer predisposing genes in unselected patients with pancreatic cancer

Genotyping and mRNA profiling reveal actionable targets in biliary tract cancers

The genome sequence of Schizosaccharomyces pombe

Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer

Pulmonary Langerhans cell histiocytosis in a patient previously treated for germ cell tumor

6503 Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

Gemcitabine combined with the MTOR Inhibitor Temsirolimus(CCI-779) in Patients with Inoperable or Metastatic Pancreatic Cancer (He 3/07). A Phase I Study by the Hellenic Cooperative Oncology Group

Molecular Characterization of a Human DNA Kinase

Correlation of MDR 1 Expression and CA 125 in Ovarian Cancer

Cloning, mapping and expression of UBL3, a novel ubiquitin-like gene

A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein

The cohesin complex: sequence homologies, interaction networks and shared motifs

Suchergebnisse filtern